• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病与阿尔茨海默病:细胞脂毒性的新作用。

Type 2 Diabetes and Alzheimer's Disease: The Emerging Role of Cellular Lipotoxicity.

机构信息

Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, 70124 Bari, Italy.

Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, 70124 Bari, Italy.

出版信息

Biomolecules. 2023 Jan 16;13(1):183. doi: 10.3390/biom13010183.

DOI:10.3390/biom13010183
PMID:36671568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9855893/
Abstract

Type 2 diabetes (T2D) and Alzheimer's diseases (AD) represent major health issues that have reached alarming levels in the last decades. Although growing evidence demonstrates that AD is a significant comorbidity of T2D, and there is a ~1.4-2-fold increase in the risk of developing AD among T2D patients, the involvement of possible common triggers in the pathogenesis of these two diseases remains largely unknown. Of note, recent mechanistic insights suggest that lipotoxicity could represent the missing ring in the pathogenetic mechanisms linking T2D to AD. Indeed, obesity, which represents the main cause of lipotoxicity, has been recognized as a major risk factor for both pathological conditions. Lipotoxicity can lead to inflammation, insulin resistance, oxidative stress, ceramide and amyloid accumulation, endoplasmic reticulum stress, ferroptosis, and autophagy, which are shared biological events in the pathogenesis of T2D and AD. In the current review, we try to provide a critical and comprehensive view of the common molecular pathways activated by lipotoxicity in T2D and AD, attempting to summarize how these mechanisms can drive future research and open the way to new therapeutic perspectives.

摘要

2 型糖尿病(T2D)和阿尔茨海默病(AD)是两个主要的健康问题,在过去几十年中已经达到了令人担忧的水平。尽管越来越多的证据表明 AD 是 T2D 的一个重要合并症,并且 T2D 患者患 AD 的风险增加了 1.4-2 倍,但这两种疾病发病机制中可能存在共同触发因素仍知之甚少。值得注意的是,最近的机制研究表明,脂毒性可能是将 T2D 与 AD 联系起来的发病机制中缺失的一环。事实上,肥胖是脂毒性的主要原因,已被认为是这两种病理状况的主要危险因素。脂毒性可导致炎症、胰岛素抵抗、氧化应激、神经酰胺和淀粉样蛋白积累、内质网应激、铁死亡和自噬,这些都是 T2D 和 AD 发病机制中的共同生物学事件。在本综述中,我们试图提供一个关于 T2D 和 AD 中脂毒性激活的共同分子途径的批判性和全面的观点,试图总结这些机制如何能够推动未来的研究并为新的治疗前景开辟道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64d9/9855893/c15c6ebfa770/biomolecules-13-00183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64d9/9855893/c15c6ebfa770/biomolecules-13-00183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64d9/9855893/c15c6ebfa770/biomolecules-13-00183-g001.jpg

相似文献

1
Type 2 Diabetes and Alzheimer's Disease: The Emerging Role of Cellular Lipotoxicity.2 型糖尿病与阿尔茨海默病:细胞脂毒性的新作用。
Biomolecules. 2023 Jan 16;13(1):183. doi: 10.3390/biom13010183.
2
An update on potential links between type 2 diabetes mellitus and Alzheimer's disease.2 型糖尿病与阿尔茨海默病之间潜在关联的最新研究进展。
Mol Biol Rep. 2020 Aug;47(8):6347-6356. doi: 10.1007/s11033-020-05693-z. Epub 2020 Aug 1.
3
Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets.将阿尔茨海默病与糖尿病联系起来:潜在机制和潜在治疗靶点。
Neuropharmacology. 2018 Jul 1;136(Pt B):160-171. doi: 10.1016/j.neuropharm.2017.11.014. Epub 2017 Nov 10.
4
From obesity to Alzheimer's disease through insulin resistance.从肥胖症到阿尔茨海默病,皆与胰岛素抵抗有关。
J Diabetes Complications. 2021 Nov;35(11):108026. doi: 10.1016/j.jdiacomp.2021.108026. Epub 2021 Aug 18.
5
SGLT2 and DPP4 inhibitors improve Alzheimer's disease-like pathology and cognitive function through distinct mechanisms in a T2D-AD mouse model.SGLT2 和 DPP4 抑制剂通过在 T2D-AD 小鼠模型中不同的机制改善阿尔茨海默病样病理和认知功能。
Biomed Pharmacother. 2023 Dec;168:115755. doi: 10.1016/j.biopha.2023.115755. Epub 2023 Oct 21.
6
Alpha-1-Antichymotrypsin: A Common Player for Type 2 Diabetes and Alzheimer's Disease.α1-抗胰蛋白酶:2 型糖尿病和阿尔茨海默病的常见参与者。
Curr Diabetes Rev. 2021;17(5):e121020186817. doi: 10.2174/1573399816999201012200537.
7
High-sugar diets, type 2 diabetes and Alzheimer's disease.高糖饮食、2 型糖尿病和阿尔茨海默病。
Curr Opin Clin Nutr Metab Care. 2013 Jul;16(4):440-5. doi: 10.1097/MCO.0b013e328361c7d1.
8
Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes.阿尔茨海默病和 2 型糖尿病混合小鼠模型中的加速淀粉样血管病及相关血管改变。
Fluids Barriers CNS. 2022 Nov 7;19(1):88. doi: 10.1186/s12987-022-00380-6.
9
Caveolin: A New Link Between Diabetes and AD.窖蛋白:糖尿病与 AD 之间的新联系。
Cell Mol Neurobiol. 2020 Oct;40(7):1059-1066. doi: 10.1007/s10571-020-00796-4. Epub 2020 Jan 23.
10
Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin.阿尔茨海默病与糖尿病:线粒体、氧化应激和胰岛素作用的综合观点
J Alzheimers Dis. 2012;30 Suppl 2:S199-215. doi: 10.3233/JAD-2011-111127.

引用本文的文献

1
Unraveling novel mechanisms of ATP-Binding cassette (ABC) transporter in insulin Resistance-induced amyloidogenesis.揭示ATP结合盒(ABC)转运蛋白在胰岛素抵抗诱导的淀粉样蛋白生成中的新机制。
Metab Brain Dis. 2025 Jun 7;40(5):218. doi: 10.1007/s11011-025-01642-6.
2
Relationship between Alzheimer's Disease and Type 2 Diabetes: Critical Review On Cellular and Molecular Common Pathogenic Mechanisms.阿尔茨海默病与2型糖尿病之间的关系:关于细胞和分子共同致病机制的批判性综述
Curr Alzheimer Res. 2025;22(2):92-122. doi: 10.2174/0115672050375461250325074826.
3
Ceramide as a Promising Tool for Diagnosis and Treatment of Clinical Diseases: A Review of Recent Advances.

本文引用的文献

1
Polydatin prevents lipotoxicity-induced dysfunction in pancreatic β-cells by inhibiting endoplasmic reticulum stress and excessive autophagy.虎杖苷通过抑制内质网应激和过度自噬来防止脂毒性诱导的胰岛β细胞功能障碍。
Phytomedicine. 2022 Nov;106:154410. doi: 10.1016/j.phymed.2022.154410. Epub 2022 Aug 20.
2
ER stress and UPR in Alzheimer's disease: mechanisms, pathogenesis, treatments.阿尔茨海默病中的内质网应激和未折叠蛋白反应:机制、发病机制、治疗方法。
Cell Death Dis. 2022 Aug 15;13(8):706. doi: 10.1038/s41419-022-05153-5.
3
Emerging Pathophysiological Mechanisms Linking Diabetes Mellitus and Alzheimer's Disease: An Old Wine in a New Bottle.
神经酰胺作为临床疾病诊断与治疗的一种有前景的工具:近期进展综述
Metabolites. 2025 Mar 11;15(3):195. doi: 10.3390/metabo15030195.
4
Neuronal CD59 isoforms IRIS-1 and IRIS-2 as regulators of neurotransmitter release with implications for Alzheimer's disease.神经元CD59亚型IRIS-1和IRIS-2作为神经递质释放的调节因子及其与阿尔茨海默病的关联
Alzheimers Res Ther. 2025 Jan 7;17(1):11. doi: 10.1186/s13195-024-01660-z.
5
Comprehensive biomarker analysis of metabolomics in different syndromes in traditional Chinese medical for prediabetes mellitus.中医不同证型糖尿病前期代谢组学的综合生物标志物分析
Chin Med. 2024 Aug 25;19(1):114. doi: 10.1186/s13020-024-00983-1.
6
Causal Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.2型糖尿病与阿尔茨海默病之间的因果关联:一项两样本孟德尔随机化研究。
J Alzheimers Dis Rep. 2024 Jun 18;8(1):945-957. doi: 10.3233/ADR-240053. eCollection 2024.
7
Insulin resistance as the molecular link between diabetes and Alzheimer's disease.胰岛素抵抗作为糖尿病与阿尔茨海默病之间的分子联系。
World J Diabetes. 2024 Jul 15;15(7):1430-1447. doi: 10.4239/wjd.v15.i7.1430.
8
The Cellular Stability Hypothesis: Evidence of Ferroptosis and Accelerated Aging-Associated Diseases as Newly Identified Nutritional Pentadecanoic Acid (C15:0) Deficiency Syndrome.细胞稳定性假说:作为新发现的营养性十五烷酸(C15:0)缺乏综合征,铁死亡和加速衰老相关疾病的证据。
Metabolites. 2024 Jun 23;14(7):355. doi: 10.3390/metabo14070355.
9
Improvement of Theaflavins on Glucose and Lipid Metabolism in Diabetes Mellitus.茶黄素对糖尿病患者糖脂代谢的改善作用
Foods. 2024 Jun 4;13(11):1763. doi: 10.3390/foods13111763.
10
HDL levels modulate the impact of type 2 diabetes susceptibility alleles in older adults.高密度脂蛋白水平调节 2 型糖尿病易感等位基因在老年人中的影响。
Lipids Health Dis. 2024 Feb 22;23(1):56. doi: 10.1186/s12944-024-02039-7.
将糖尿病与阿尔茨海默病联系起来的新兴病理生理机制:旧瓶装新酒
J Alzheimers Dis Rep. 2022 Jun 22;6(1):349-357. doi: 10.3233/ADR-220021. eCollection 2022.
4
Contribution of specific ceramides to obesity-associated metabolic diseases.特定神经酰胺对肥胖相关代谢性疾病的作用。
Cell Mol Life Sci. 2022 Jul 5;79(8):395. doi: 10.1007/s00018-022-04401-3.
5
Adipose Tissue Secretion Pattern Influences β-Cell Wellness in the Transition from Obesity to Type 2 Diabetes.脂肪组织分泌模式影响肥胖向 2 型糖尿病转变过程中的β细胞功能。
Int J Mol Sci. 2022 May 15;23(10):5522. doi: 10.3390/ijms23105522.
6
The p66Shc Protein Mediates Insulin Resistance and Secretory Dysfunction in Pancreatic β-Cells Under Lipotoxic Conditions.p66Shc蛋白在脂毒性条件下介导胰腺β细胞的胰岛素抵抗和分泌功能障碍。
Diabetes. 2022 Aug 1;71(8):1763-1771. doi: 10.2337/db21-1066.
7
Antidiabetic Drugs in the Treatment of Alzheimer's Disease.抗糖尿病药物治疗阿尔茨海默病。
Int J Mol Sci. 2022 Apr 22;23(9):4641. doi: 10.3390/ijms23094641.
8
A New Hypothesis for Alzheimer's Disease: The Lipid Invasion Model.阿尔茨海默病的一个新假说:脂质入侵模型。
J Alzheimers Dis Rep. 2022 Mar 25;6(1):129-161. doi: 10.3233/ADR-210299. eCollection 2022.
9
Promise of irisin to attenuate cognitive dysfunction in aging and Alzheimer's disease.鸢尾素在衰老和阿尔茨海默病认知功能障碍中的应用前景。
Ageing Res Rev. 2022 Jun;78:101637. doi: 10.1016/j.arr.2022.101637. Epub 2022 Apr 30.
10
Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer's Disease: Review and Meta-Analysis.2型糖尿病作为阿尔茨海默病的一个风险因素:综述与荟萃分析
Biomedicines. 2022 Mar 27;10(4):778. doi: 10.3390/biomedicines10040778.